Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-21

FDA Approved: PALONOSETRON — Original Application (NorthStar Rx LLC)

View source ↗

Summary

FDA approved NorthStar Rx LLC's palonosetron as an original application (ANDA201533) for preventing postoperative and chemotherapy-induced nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron (palonosetron)

Snippet

ORIG AP for PALONOSETRON (PALONOSETRON)